Artemether Lumefantrine Suspension

Artemether + Lumefantrine is classed as a artemisinin-based combination antimalarial and is supplied as oral suspension. Its standard indications include uncomplicated Plasmodium falciparum malaria, and it is offered for pharmaceutical supply and export.

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.